By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Synthetic Genomics and the non-profit J. Craig Venter Institute today announced that they have formed a new company, called Synthetic Genomics Vaccines, focused on genomic-based vaccines.

The partners, both based in La Jolla, Calif., and co-founded by Craig Venter, said they will develop next-generation vaccines using JCVI's genomic sequencing and synthetic genomic research expertise.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.